Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase

Arch Pharm Res. 2003 Mar;26(3):197-201. doi: 10.1007/BF02976829.

Abstract

Novel beta-hydroxy propenamides as analogues of the active metabolite of leflunomide (A 771726) were synthesized and evaluated for their inhibitory activity on dihydroorotate dehydrogenase (DHODH) in an investigation into their immunosuppressive activity. Compounds 2a, 3a, and 3h were approximately 4-40 times more potent than leflunomide in their activity while they were-less active than A 771726.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds / chemical synthesis*
  • Aniline Compounds / chemistry
  • Aniline Compounds / pharmacology
  • Crotonates
  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors / chemical synthesis*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Hydroxybutyrates / chemical synthesis*
  • Hydroxybutyrates / chemistry
  • Hydroxybutyrates / pharmacology
  • Isoxazoles / metabolism
  • Leflunomide
  • Nitriles
  • Oxidoreductases Acting on CH-CH Group Donors / antagonists & inhibitors*
  • Oxidoreductases Acting on CH-CH Group Donors / metabolism
  • Toluidines

Substances

  • Aniline Compounds
  • Crotonates
  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors
  • Hydroxybutyrates
  • Isoxazoles
  • Nitriles
  • Toluidines
  • teriflunomide
  • Oxidoreductases Acting on CH-CH Group Donors
  • Leflunomide